Affinity Asset Advisors, LLC: 13F holdings
CIK 17731952026Q2
| Positions | 110 |
|---|
| Reported value | $2.2bn |
|---|
| Filed | 2026-08-13 |
|---|
Change since last quarter
| Positions | 110 (+7 vs prior quarter) |
|---|
| Reported value | $2.2bn (+14.3%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| ROIVANT SCIENCES LTD | 3,750,000 | $132.7m | 6.0% |
| APOGEE THERAPEUTICS INC | 987,000 | $131.0m | 5.9% |
| SYRE SPYRE THERAPEUTICS INC | 1,279,134 | $113.6m | 5.1% |
| XENE XENON PHARMACEUTICALS INC | 1,595,000 | $96.3m | 4.4% |
| ERAS ERASCA INC | 5,250,000 | $96.2m | 4.3% |
| INSM INSMED INC | 650,000 | $69.3m | 3.1% |
| PRAX PRAXIS PRECISION MEDICINES I | 185,000 | $61.9m | 2.8% |
| ALKERMES PLC | 1,125,000 | $58.9m | 2.7% |
| ORKA ORUKA THERAPEUTICS INC | 590,000 | $56.2m | 2.5% |
| ANAB ANAPTYSBIO INC | 826,109 | $55.8m | 2.5% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1773195")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples